EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanomaterial-based biosensors for cancer diagnosis: trends and innovations (2022–2025)

Amal Adnan Ashour, Faris J Tayeb, Mohammed Fareed Felemban, Alaa Shafie

Microchimica Acta · 2025-07 · 192 (7)

DOI: 10.1007/s00604-025-07276-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microchimica Acta, online erschienen am 04.06.2025. Verfasst von Amal Adnan Ashour und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral & Maxillofacial Surgery and Diagnostic Sciences, Faculty of Dentistry, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia. Hauptthemen laut MEDLINE: Biosensing Techniques, Neoplasms, Biomarkers, Tumor, Nanostructures. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 84 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a significant global health concern, with its prevalence continuing to rise steadily. Early detection is vital for improving treatment outcomes and survival rates by enabling timely intervention and effective disease management. Biosensors have emerged as crucial tools in cancer diagnosis, offering high sensitivity, selectivity, and rapid detection of biomarkers. Among them, nanomaterial-based biosensors have gained significant attention due to their unique properties, including enhanced biocompatibility, stability, and large surface area for biomolecule interaction. These sensors utilize materials like metal nanoparticles, quantum dots, and other nanomaterials, which amplify signals and improve detection limits, making them highly effective for identifying cancer at its earliest stages. Their adaptability and potential for multiplexed detection further highlight their value in advancing cancer diagnostics and treatment strategies. This review explores recent advancements in nanomaterial-based biosensors for detecting cancer-related biomarkers, highlighting their critical role in early diagnosis. Key biomarkers covered include CA15-3, GPC3, Cyfra 21-1, CA-125, CRT, PDGF, PSA, miRNA-122, Anti-P53, YES1, CEA, PSMA, miR-141, c-Met protein, miR-106b, HER-2, Pax-5a, mSEPT9, and miR-21. By focusing on studies conducted between 2022 and 2025, the review addresses emerging applications and future prospects of these biosensors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesNeoplasmsBiomarkers, TumorNanostructuresHumans

Stichwörter der Autor:innen

BiocompatibilityBiosensorsCancer identificationMetal nanoparticles

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Oral & Maxillofacial Surgery and Diagnostic Sciences, Faculty of Dentistry, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia.
  • Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia.
  • Department of Maxillofacial Surgery and Diagnostic Science, Faculty of Dentistry, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia. a.shafie@tu.edu.sa.

Zitieren

APA

Ashour, A. A., Tayeb, F. J., Felemban, M. F., & Shafie, A. (2025). Nanomaterial-based biosensors for cancer diagnosis: trends and innovations (2022–2025). Microchimica Acta, 192(7). https://doi.org/10.1007/s00604-025-07276-w

Vancouver

Ashour AA, Tayeb FJ, Felemban MF, Shafie A. Nanomaterial-based biosensors for cancer diagnosis: trends and innovations (2022–2025). Microchimica Acta. 2025;192(7). doi:10.1007/s00604-025-07276-w

BibTeX
@article{Ashour2025,
  author = {Ashour, Amal Adnan and Tayeb, Faris J and Felemban, Mohammed Fareed and Shafie, Alaa},
  title = {Nanomaterial-based biosensors for cancer diagnosis: trends and innovations (2022–2025)},
  journal = {Microchimica Acta},
  year = {2025},
  volume = {192},
  number = {7},
  doi = {10.1007/s00604-025-07276-w}
}
Kostenlos starten →